Over the past decade, few areas of medicine have captured both scientific and public attention as dramatically as GLP-1 (glucagon-like peptide-1)-based therapies
In this preclinical study, we investigated how alcohol, fluoxetine, and their combination affect the gut microbiota, intestinal barrier integrity, peripheral inflammatory markers, and neuroimmune signaling
[DOI] [PubMed] [Google Scholar] 3.Flegal KM, Kit BK, Orpana H, Graubard BI
By reducing adipose tissue mass, improving lipid profiles, and enhancing mitochondrial function, NNMT inhibition addresses multiple pathways involved in metabolic syndrome development
These compounds are sold strictly for in vitro laboratory research and are not approved for human consumption.